These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37317998)

  • 21. Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors.
    Mehrazar M; Hassankalhori M; Toolabi M; Goli F; Moghimi S; Nadri H; Bukhari SNA; Firoozpour L; Foroumadi A
    Mol Divers; 2020 Nov; 24(4):997-1013. PubMed ID: 31845210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.
    Turky A; Bayoumi AH; Sherbiny FF; El-Adl K; Abulkhair HS
    Mol Divers; 2021 Feb; 25(1):403-420. PubMed ID: 32830299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, anticancer activity and molecular modeling study of novel substituted triazole linked tetrafluoronaphthalene hybrid derivatives.
    Erdoğan M; Comert Onder F
    J Biomol Struct Dyn; 2024 Nov; 42(18):9767-9786. PubMed ID: 37676264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies.
    Chigurupati S; Selvaraj M; Mani V; Selvarajan KK; Mohammad JI; Kaveti B; Bera H; Palanimuthu VR; Teh LK; Salleh MZ
    Bioorg Chem; 2016 Aug; 67():9-17. PubMed ID: 27231830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conventional and microwave prompted synthesis, antioxidant, anticholinesterase activity screening and molecular docking studies of new quinolone-triazole hybrids.
    Mermer A; Demirbaş N; Şirin Y; Uslu H; Özdemir Z; Demirbaş A
    Bioorg Chem; 2018 Aug; 78():236-248. PubMed ID: 29614435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Elwan A
    Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
    Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
    Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study.
    Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J
    Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, Synthesis, biological investigations and molecular interactions of triazole linked tacrine glycoconjugates as Acetylcholinesterase inhibitors with reduced hepatotoxicity.
    Kaur Gulati H; Choudhary S; Kumar N; Ahmed A; Bhagat K; Vir Singh J; Singh A; Kumar A; Singh Bedi PM; Singh H; Mukherjee D
    Bioorg Chem; 2022 Jan; 118():105479. PubMed ID: 34801945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and in silico insights of novel 1,2,3-triazole benzenesulfonamide derivatives as potential carbonic anhydrase IX and XII inhibitors with promising anticancer activity.
    Abdelhakeem MM; Morcoss MM; Hanna DA; Lamie PF
    Bioorg Chem; 2024 Mar; 144():107154. PubMed ID: 38309003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbazole-based semicarbazones and hydrazones as multifunctional anti-Alzheimer agents.
    Patel KB; Patel DV; Patel NR; Kanhed AM; Teli DM; Gandhi B; Shah BS; Chaudhary BN; Prajapati NK; Patel KV; Yadav MR
    J Biomol Struct Dyn; 2022; 40(20):10278-10299. PubMed ID: 34215173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A biochemistry-oriented drug design: synthesis, anticancer activity, enzymes inhibition, molecular docking studies of novel 1,2,4-triazole derivatives.
    Yuriy K; Kusdemir G; Volodymyr P; Tüzün B; Taslimi P; Karatas OF; Anastasia K; Maryna P; Sayın K
    J Biomol Struct Dyn; 2024; 42(3):1220-1236. PubMed ID: 37671856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer's disease.
    Le-Nhat-Thuy G; Nguyen Thi N; Pham-The H; Dang Thi TA; Nguyen Thi H; Nguyen Thi TH; Nguyen Hoang S; Nguyen TV
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127404. PubMed ID: 32717612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-oxadiazole-1,2,3-triazole Hybrids.
    Mohammadi-Khanaposhtani M; Mahdavi M; Saeedi M; Sabourian R; Safavi M; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
    Chem Biol Drug Des; 2015 Dec; 86(6):1425-32. PubMed ID: 26077890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
    Hasan AH; Murugesan S; Amran SI; Chander S; Alanazi MM; Hadda TB; Shakya S; Pratama MRF; Das B; Biswas S; Jamalis J
    Bioorg Chem; 2022 Feb; 119():105572. PubMed ID: 34971946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosol 1,2,3-triazole analogues as new acetylcholinesterase (AChE) inhibitors.
    Bousada GM; de Sousa BL; Furlani G; Agrizzi AP; Ferreira PG; Leite JPV; Mendes TAO; Varejão EVV; Pilau EJ; Dos Santos MH
    Comput Biol Chem; 2020 Oct; 88():107359. PubMed ID: 32853899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
    Singh A; Sharma S; Arora S; Attri S; Kaur P; Kaur Gulati H; Bhagat K; Kumar N; Singh H; Vir Singh J; Mohinder Singh Bedi P
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127477. PubMed ID: 32781220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.